Fetal thyrotoxicosis is a rare condition with high morbidity and mortality. It may complicate pregnancies in women with a history of Graves disease (GD) when transplacental passage of maternal TSH receptor antibodies stimulate the fetal thyroid gland and cause hyperthyroidism. We report the case of a 34-year-old woman with a history of GD and prior thyroidectomy, where fetal thyrotoxicosis at 21 weeks of gestation was suspected due to prenatal ultrasound findings of cardiac failure and fetal goiter. She was treated with high-dose carbimazole and followed closely by a multidisciplinary team. Her baby was delivered in good condition at 34 weeks' gestation and developed hyperthyroidism in the days after birth, which was successfully treated medically. This case highlights the importance of awareness of the condition among women with a history of GD, as well as the necessity for prompt diagnosis and treatment of this complex disease.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11017107PMC
http://dx.doi.org/10.1210/jcemcr/luae060DOI Listing

Publication Analysis

Top Keywords

fetal thyrotoxicosis
12
graves disease
8
women history
8
fetal
5
maternal graves
4
disease postthyroidectomy
4
postthyroidectomy fetal
4
thyrotoxicosis goiter
4
goiter fetal
4
thyrotoxicosis rare
4

Similar Publications

Clinical Application of Thyrotropin Receptor Antibodies.

Horm Metab Res

December 2024

Department of Endocrinology and Metabolism, Lanzhou University Second Clinical Medical School, Lanzhou, China.

Thyrotropin receptor antibodies (TRAb) are specific for Graves' disease (GD) and play a crucial role in the pathogenesis of GD. TRAb assays have recently been greatly improved. This review discusses the clinical application of TRAb in the differential diagnosis of hyperthyroidism, the prognosis of GD, GD in gestation and pediatrics, and GD related ophthalmopathy (GO).

View Article and Find Full Text PDF

From Syncope to Pregnancy: A Case Report of Gestational Transient Thyrotoxicosis.

Cureus

September 2024

Department of Endocrinology, Diabetes, and Metabolism, Centro Hospitalar Universitário de Santo António, Unidade Local de Saúde de Santo António, Porto, PRT.

With a multifactorial etiology, syncope is a fairly common clinical presentation in emergency care. During pregnancy, it can result from hemodynamic and hormonal changes. One such rare cause is hyperthyroidism.

View Article and Find Full Text PDF

Assessing the Quality of Care of Pregnant Patients With Thyrotoxicosis at an Urban Safety Net Hospital.

Endocr Pract

January 2025

Section of Endocrinology, Diabetes, Nutrition, and Weight Management, Boston University Aram V. Chobanian & Edward Avedisian School of Medicine, Boston, Massachusetts. Electronic address:

Objective: Thyrotoxicosis can adversely affect pregnancy. The quality of care (QoC) for thyrotoxicosis in pregnancy at a tertiary care safety net hospital was evaluated based on current guidelines.

Methods: Pregnant patients with thyrotoxicosis or a history of Graves disease who delivered in 2015-2021 were divided into 3 groups: low thyroid stimulating hormone (TSH), active Graves disease, and past Graves disease.

View Article and Find Full Text PDF

Fetal and neonatal thyrotoxicosis occurs in up to 5% of pregnancies in mothers with Graves' disease (GD). This condition is caused by stimulating antibodies against the thyrotropin receptor (TRAbs) that cross the placenta and may stimulate the fetal thyroid, typically in the second half of pregnancy. GD is often treated with radioiodine, resulting in hypothyroidism in most patients, but TRAbs can persist for several years.

View Article and Find Full Text PDF

Neuroendocrinology of bone.

Pituitary

December 2024

Mount Sinai Center of Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.

Article Synopsis
  • The last ten years have greatly improved our knowledge of bone health and the processes behind bone loss in osteoporosis, both primary and secondary.
  • Key discoveries have come from studying bone diseases in people and creating similar conditions in genetically altered rodents, revealing that pituitary hormones play important roles in bone health beyond just affecting other hormone-producing glands.
  • Specific hormones like follicle-stimulating hormone (FSH) and thyroid-stimulating hormone (TSH) have been linked to rapid bone loss during menopause and thyroid issues, respectively, while hormones like oxytocin and prolactin may influence bone health across generations.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!